An ultrasensitive blood test detecting low levels of ctDNA could help to improve disease stratification in early-stage lung adenocarcinoma.
Rheumatology patients are increasingly accepting digital health technologies, highlighting the need for standardised tracking ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback